Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
25
2023
Real Estate Beneficial Ownership Regulatory Alert: Complying with Foreign Ownership Reporting Requirements in US Real Estate K&L Gates
Jul
25
2023
Big Tobacco Bets Big On Cannabis Bradley Arant Boult Cummings LLP
Jul
25
2023
Washington State’s Aggressive Approach to Preventing Intoxicating Hemp Cannabinoids May Be Adopted in Other States Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
24
2023
Regulators Send Warning Letter to Hospitals and Telehealth Providers About Tracking Technology Use Sheppard, Mullin, Richter & Hampton LLP
Jul
21
2023
EPA Extends Comment Period on Proposed SNURs for 18 Chemicals Made from Plastic Waste-Based Feedstocks Bergeson & Campbell, P.C.
Jul
21
2023
Reintroduced Bill Seeks Legal Pathway for CBD in Food Keller and Heckman LLP
Jul
21
2023
Post-Dobbs Hospital Risk Assessment, Part 2: Impacts Beyond Abortion ArentFox Schiff LLP
Jul
20
2023
Changing Landscape: Federal and State Regulators Focus on Protecting Consumer Health Data Foley & Lardner LLP
Jul
20
2023
U.S. Executive Branch Update – July 20, 2023 Squire Patton Boggs (US) LLP
Jul
20
2023
Lab Study Shows Oral Antacid Drug Performs Differently When Mixed with Various Food Vehicles Keller and Heckman LLP
Jul
19
2023
EPA Announces Release of Guidance for the Evaluation of Products for Claims against Viruses Bergeson & Campbell, P.C.
Jul
19
2023
USDA FSIS Implements Directives to Inspection Program Personnel as Cell-Cultured Meats Begin to Enter the U.S. Market. Keller and Heckman LLP
Jul
19
2023
Trending in Telehealth: June 27 – July 10, 2023 McDermott Will & Emery
Jul
19
2023
IP Toolbox Is Crucial In AI-Powered Drug Discovery Foley & Lardner LLP
Jul
18
2023
Complex Healthcare Litigation Toolkit: The Use of Plaintiff Fact Sheets and Summary Jury Trials Foley & Lardner LLP
Jul
18
2023
U.S. Executive Branch Update – July 18, 2023 Squire Patton Boggs (US) LLP
Jul
18
2023
EPA Extends Comment Period on Proposed Updates to TSCA New Chemicals Regulations; Comments Due August 8, 2023 Bergeson & Campbell, P.C.
Jul
18
2023
Hospital Price Transparency Changes in the Calendar Year 2024 Hospital Outpatient Prospective Payment System Proposed Rule Nelson Mullins
Jul
18
2023
District of Columbia Employers Take Notice: City’s Cannabis Employment Protections Amendments Act Takes Effect ArentFox Schiff LLP
Jul
18
2023
Report: Digital Health in India in 2023 Nishith Desai Associates
Jul
18
2023
This Week in 340B: July 6 – 17, 2023 McDermott Will & Emery
Jul
18
2023
Those Aren’t Doritos: FTC and FDA Send Warning Letters to Companies Marketing Delta-8 Infused Munchies Mintz
Jul
18
2023
Montana Enacts Genetic Information Privacy Law Jackson Lewis P.C.
Jul
17
2023
California Assembly Passes Bill that Would Prohibit Certain Food Additives Greenberg Traurig, LLP
Jul
17
2023
In a Landmark Decision, China’s Supreme Court Reverses Lower Court Decision Banning Excessively High Prices on a Patent-Protected Pharmaceutical Product Greenberg Traurig, LLP
Jul
17
2023
Healthcare Preview for The Week Of: July 17, 2023 McDermott Will & Emery
Jul
17
2023
Petition Filed to Add Methyl Ethyl Ketoxime to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Jul
17
2023
SEC Cannabis Enforcement Continuing to Grow this Past Spring Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins